...
search icon
hura-img

TuHURA Biosciences Inc, Common Stock

HURA

NAQ

$2.83

-$0.18

(-5.98%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$171.23M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
111.85K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.8 L
$14.6 H
$2.83

About TuHURA Biosciences Inc, Common Stock

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-specific antibody-peptide conjugates and antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameHURASectorS&P500
1-Week Return-25.78%-1.91%-1.87%
1-Month Return-30.73%-3.82%8.93%
3-Month Return0.33%-11.56%-2.39%
6-Month Return-13.41%-10.21%-2.41%
1-Year Return-47.05%-9.91%10.88%
3-Year Return-98.91%-0.28%46.93%
5-Year Return-99.82%31.29%94.89%
10-Year Return-99.98%75.9%177.5%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Cost of Revenue10.00K32.00K---[{"date":"2020-06-30","value":31.25,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit(10.00K)(32.00K)---[{"date":"2020-06-30","value":-1000000,"profit":false},{"date":"2021-06-30","value":-3200000,"profit":false},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Operating Expenses8.13M21.54M7.25M9.93M29.76M[{"date":"2020-06-30","value":27.33,"profit":true},{"date":"2021-06-30","value":72.37,"profit":true},{"date":"2022-06-30","value":24.37,"profit":true},{"date":"2023-06-30","value":33.37,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Income(8.14M)(21.57M)(7.25M)(9.93M)(29.76M)[{"date":"2020-06-30","value":-814400000,"profit":false},{"date":"2021-06-30","value":-2157200000,"profit":false},{"date":"2022-06-30","value":-725498100,"profit":false},{"date":"2023-06-30","value":-993385100,"profit":false},{"date":"2024-06-30","value":-2976472000,"profit":false}]
Total Non-Operating Income/Expense--(390.81K)623.69K518.88K[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":-62.66,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":83.2,"profit":true}]
Pre-Tax Income(9.13M)(38.30M)(7.02M)(9.37M)(29.32M)[{"date":"2020-06-30","value":-912600000,"profit":false},{"date":"2021-06-30","value":-3829800000,"profit":false},{"date":"2022-06-30","value":-701650900,"profit":false},{"date":"2023-06-30","value":-936751300,"profit":false},{"date":"2024-06-30","value":-2931682600,"profit":false}]
Income Taxes----(1.00)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":-100,"profit":false}]
Income After Taxes----(29.32M)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":-2931682500,"profit":false}]
Income From Continuous Operations--(7.02M)(9.37M)(29.32M)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":-701650900,"profit":false},{"date":"2023-06-30","value":-936751300,"profit":false},{"date":"2024-06-30","value":-2931682600,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(9.13M)(38.30M)(7.02M)(9.37M)(29.32M)[{"date":"2020-06-30","value":-912600000,"profit":false},{"date":"2021-06-30","value":-3829800000,"profit":false},{"date":"2022-06-30","value":-701650900,"profit":false},{"date":"2023-06-30","value":-936751300,"profit":false},{"date":"2024-06-30","value":-2931682500,"profit":false}]
EPS (Diluted)(1.53K)(3.46K)(979.26)(328.34)-[{"date":"2020-06-30","value":-152505.28,"profit":false},{"date":"2021-06-30","value":-346177.6,"profit":false},{"date":"2022-06-30","value":-97926.21,"profit":false},{"date":"2023-06-30","value":-32834.25,"profit":false},{"date":"2024-06-30","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HURA
Current Ratio 3.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HURA
ROA (LTM) -90.68%
ROE (LTM) -332.67%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HURA
Debt Ratio Lower is generally better. Negative is bad. 0.33
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.67

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HURA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 13.73
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is TuHURA Biosciences Inc share price today?

TuHURA Biosciences Inc (HURA) share price today is $2.83

Can Indians buy TuHURA Biosciences Inc shares?

Yes, Indians can buy shares of TuHURA Biosciences Inc (HURA) on Vested. To buy TuHURA Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HURA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of TuHURA Biosciences Inc be purchased?

Yes, you can purchase fractional shares of TuHURA Biosciences Inc (HURA) via the Vested app. You can start investing in TuHURA Biosciences Inc (HURA) with a minimum investment of $1.

How to invest in TuHURA Biosciences Inc shares from India?

You can invest in shares of TuHURA Biosciences Inc (HURA) via Vested in three simple steps:

  • Click on Sign Up or Invest in HURA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in TuHURA Biosciences Inc shares
What is TuHURA Biosciences Inc 52-week high and low stock price?

The 52-week high price of TuHURA Biosciences Inc (HURA) is $14.6. The 52-week low price of TuHURA Biosciences Inc (HURA) is $1.8.

What is TuHURA Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of TuHURA Biosciences Inc (HURA) is 13.73

What is the Market Cap of TuHURA Biosciences Inc?

The market capitalization of TuHURA Biosciences Inc (HURA) is $171.23M

What is TuHURA Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of TuHURA Biosciences Inc is HURA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top